Yuanke Liang

1.1k citations

30 papers · 752 indexed · h-index 16

Co-authors: Haoyu Lin De Zeng Chunfa Chen Xiaolong Wei Guo‐Jun Zhang Yingsheng Xiao Jing‐Wen Bai Frank A.E. Kruyt
Topics: Cancer Cells and Metastasis (10 papers)Epigenetics and DNA Methylation (5 papers)Nanoplatforms for cancer theranostics (4 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: PLoS ONE Cancer Research International Journal of Molecular Sciences
Partner nations: China Netherlands Hong Kong

In The Last Decade

Yuanke Liang

28 papers receiving 741 citations

Peers

Countries citing papers authored by Yuanke Liang

Since Specialization

Citations

This map shows the geographic impact of Yuanke Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanke Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanke Liang more than expected).

Fields of papers citing papers by Yuanke Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanke Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanke Liang. The network helps show where Yuanke Liang may publish in the future.

Co-authorship network of co-authors of Yuanke Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanke Liang. A scholar is included among the top collaborators of Yuanke Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanke Liang. Yuanke Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing medical English proficiency: the current status and development potential of peer-assisted learning in medical education 2025 ·BMC Medical Education ·(unknown),(unknown),(unknown),(unknown),Yuanke Liang,Tian Huang,(unknown),(unknown),Gang Xin,Haoyu Lin	1
2	RC48-targeted two-dimensional black phosphorus nanoplatform for precise photothermal-immunotherapy of HER2-positive breast cancer 2025 ·Journal of Colloid and Interface Science ·(unknown),Guan‐Yuan Chen,Hongwei Lü,Xinrui Li,Shuzhao Chen,(unknown),Wen‐Xiu Ni,(unknown),Xinqiang Fang,(unknown),Benqing Zhou,Yuanke Liang	0
3	RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities 2024 ·Critical Reviews in Oncology/Hematology ·Shimeng Wang,(unknown),Guan‐Yuan Chen,Chengyu Wu,(unknown),Jiajia Lin,(unknown),De Zeng,(unknown),Guan Huang,Xiaofeng Lu,Haoyu Lin,Yuanke Liang	4
4	Abstract 1549: Molecular mechanism of CD146 nanobody in tumor metastasis inhibition mediating by IL-6/JAK/STAT3 signaling in triple-negative breast cancer 2024 ·Cancer Research ·Kaiyuan Huang,(unknown),Chengyu Wu,(unknown),Jinling Chen,Yanhan Chen,Xinqiang Fang,Shuzhao Chen,Yuanke Liang,(unknown)	0
5	HER2-targeting two-dimensional black phosphorus as a nanoplatform for chemo-photothermal therapy in breast cancer 2023 ·Materials Today Bio ·Yuanke Liang,Jinxing Liu,(unknown),(unknown),Kaiyuan Huang,(unknown),De Zeng,Haoyu Lin,Benqing Zhou	6
6	Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model 2023 ·Frontiers in Public Health ·(unknown),Joseph T. F. Lau,Yuanke Liang,(unknown),(unknown),(unknown),(unknown),(unknown),Haoyu Lin,Yanqiu Yu,De Zeng	1
7	Online short videos promoting public breast cancer literacy: a pretest-posttest control group trial on efficiency, attitude, and influencing factors 2023 ·Frontiers in Public Health ·(unknown),(unknown),(unknown),(unknown),(unknown),Yongyong Ma,De Zeng,Yuanke Liang,(unknown),(unknown),Haoyu Lin	10
8	Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy 2022 ·Frontiers in Oncology ·(unknown),Kun Wang,(unknown),Yanxia Shi,Yuanqi Zhang,Haoyu Lin,Yuanke Liang,Yingsheng Xiao,Zhiyong Wu,Zhongyu Yuan,Si-Qi Qiu	6
9	CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells 2022 ·Cancer Letters ·Yuanke Liang,Xiaoling Zhou,Qin Xie,(unknown),Kaiyuan Huang,Huan Chen,(unknown),Benqing Zhou,Xiaolong Wei,De Zeng,Haoyu Lin	23
10	CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling 2022 ·Cellular and Molecular Life Sciences ·Yuanke Liang,(unknown),Judith T.M.L. Paridaen,Nynke Oosterhof,Liang Dong,(unknown),Inge S. Zuhorn,Wilfred F.A. den Dunnen,Guo‐Jun Zhang,Haoyu Lin,Lara Barazzuol,Frank A.E. Kruyt	27
11	Associations of Obesity, Physical Activity, and Screening With State-Level Trends and Racial and Ethnic Disparities of Breast Cancer Incidence and Mortality in the US 2022 ·JAMA Network Open ·(unknown),Wei Xie,Yuanke Liang,(unknown),Jundong Wu,Yukun Cui,Xuefen Su,De Zeng	6
12	Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN 2021 ·Cell Death and Disease ·Yong‐Qu Zhang,Yuanke Liang,Yang Wu,Min Chen,Weiling Chen,Ronghui Li,(unknown),Wen‐He Huang,Jundong Wu,De Zeng,(unknown),Chunfa Chen,Haoyu Lin,Ruiqin Yang,(unknown),Wan‐Ling Liu,Jing‐Wen Bai,Min Wei,Xiaolong Wei,Guo‐Jun Zhang	34
13	CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer 2021 ·Frontiers in Oncology ·Yuanke Liang,(unknown),(unknown),Si-Qi Qiu,Yingsheng Xiao,(unknown),Qin Xie,(unknown),(unknown),De Zeng,Haoyu Lin	40
14	FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer 2020 ·Cancer Cell International ·Qin Xie,Yingsheng Xiao,(unknown),(unknown),(unknown),Yi‐Chun Chen,(unknown),Yuanke Liang,Haoyu Lin,De Zeng	16
15	O-6-methylguanine DNA methyltransferase is a favorable biomarker with proliferation suppressive potential in Breast Cancer 2020 ·Journal of Cancer ·(unknown),Yingsheng Xiao,(unknown),Xiao Wu,Chunfa Chen,Yuanke Liang,De Zeng	4
16	Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression 2018 ·Oncogenesis ·Haoyu Lin,Yuanke Liang,Xiaowei Dou,Chunfa Chen,Xiaolong Wei,De Zeng,Jing‐Wen Bai,Yuxian Guo,(unknown),Wen-Jia Chen,Caiwen Du,Yaochen Li,Min Chen,Guo‐Jun Zhang	35
17	Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells 2018 ·Cancer Letters ·Yingsheng Xiao,De Zeng,Yuanke Liang,Yang Wu,Meifang Li,(unknown),Xiaolong Wei,Wen-Jia Chen,Min Chen,Guo‐Jun Zhang	51
18	MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines 2018 ·npj Breast Cancer ·Yuanke Liang,Haoyu Lin,Xiaowei Dou,Min Chen,Xiaolong Wei,Yong‐Qu Zhang,Yang Wu,Chunfa Chen,Jing‐Wen Bai,Yingsheng Xiao,(unknown),Frank A.E. Kruyt,Guo‐Jun Zhang	58
19	Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α 2017 ·Theranostics ·Xiaowei Dou,Yuanke Liang,Haoyu Lin,Xiaolong Wei,Yong‐Qu Zhang,Jing‐Wen Bai,Chunfa Chen,Min Chen,Caiwen Du,Yaochen Li,Jie Tian,Kwan Man,Guo‐Jun Zhang	50
20	MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial–mesenchymal transition, decreased ERα expression and AKT activation 2016 ·Cancer Letters ·Yuanke Liang,De Zeng,Yingsheng Xiao,Yang Wu,(unknown),Min Chen,Yaochen Li,Haoyu Lin,Xiaolong Wei,Yong‐Qu Zhang,Frank A.E. Kruyt,Guo‐Jun Zhang	57

About Yuanke Liang

Yuanke Liang is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 30 papers that have together received 752 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Epigenetics and DNA Methylation (5 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Cancer Research (238 citations), Oncology (249 citations) and Molecular Biology (488 citations). Yuanke Liang has collaborated with scholars based in China, Netherlands and Hong Kong. Frequent co-authors include Haoyu Lin, De Zeng, Chunfa Chen, Xiaolong Wei, Guo‐Jun Zhang, Yingsheng Xiao, Jing‐Wen Bai, Frank A.E. Kruyt, Yong‐Qu Zhang and Yang Wu. Their work appears in journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact